{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:59:56Z","timestamp":1790470796937,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4256,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.fertnstert.2009.10.012","type":"journal-article","created":{"date-parts":[[2009,11,27]],"date-time":"2009-11-27T13:04:30Z","timestamp":1259327070000},"page":"1787-1792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome)"],"prefix":"10.1016","volume":"94","author":[{"given":"Louise A.","family":"Brinton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran S.","family":"Moghissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn L.","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmet J.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Scoccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2009.10.012_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/978-0-387-78818-0_10","article-title":"Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies","volume":"630","author":"Eliassen","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib2","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib3","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib4","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/humrep\/deh322","article-title":"Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?","volume":"19","author":"Legro","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Revised","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib6","first-page":"97","article-title":"Endometrial adenocarcinoma and the Stein-Leventhal syndrome","volume":"51","author":"Jafari","year":"1978","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2007-992926","article-title":"Polycystic ovary syndrome and endometrial cancer","volume":"26","author":"Navaratnarajah","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib8","first-page":"403","article-title":"Chronic anovulation syndrome and associated neoplasia","volume":"61","author":"Coulam","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib9","first-page":"124","article-title":"Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women","volume":"77","author":"Escobedo","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib10","first-page":"399","article-title":"Women younger than 50 years with endometrial cancer","volume":"27","author":"Iatrakis","year":"2006","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib11","first-page":"89","article-title":"A case-control study of uterine endometrial cancer of pre- and post-menopausal women","volume":"7","author":"Niwa","year":"2000","journal-title":"Oncol Rep"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","author":"Wild","year":"2000","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib13","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjc.6605086","article-title":"Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort","volume":"100","author":"dos Santos Silva","year":"2009","journal-title":"Br J Cancer"},{"issue":"4 Pt 1","key":"10.1016\/j.fertnstert.2009.10.012_bib14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0029-7844(96)00226-8","article-title":"Epithelial ovarian cancer risk among women with polycystic ovary syndrome","volume":"88","author":"Schildkraut","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<494::AID-CNCR10>3.0.CO;2-Z","article-title":"Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa","volume":"79","author":"Anderson","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/oxfordjournals.aje.a116156","article-title":"Polycystic ovaries and the risk of breast cancer","volume":"134","author":"Gammon","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib17","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/bjc.1997.289","article-title":"Selected medical conditions and risk of breast cancer","volume":"75","author":"Talamini","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.fertnstert.2004.02.109","article-title":"Ovarian cancer risk associated with varying causes of infertility","volume":"82","author":"Brinton","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib20","series-title":"Statistical methods in cancer research","author":"Breslow","year":"1987"},{"issue":"3 Pt 1","key":"10.1016\/j.fertnstert.2009.10.012_bib21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ajog.2005.01.091","article-title":"Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs","volume":"193","author":"Althuis","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib22","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.AOG.0000128139.92313.74","article-title":"Ovarian cancer risk after the use of ovulation-stimulating drugs","volume":"103","author":"Brinton","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib23","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/humrep\/deh371","article-title":"Breast cancer risk associated with ovulation-stimulating drugs","volume":"19","author":"Brinton","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bpobgyn.2006.04.006","article-title":"Polycystic ovarian syndrome\u2014prognosis and outcomes","volume":"20","author":"Hart","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","article-title":"Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review","volume":"19","author":"Chittenden","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib26","first-page":"353","article-title":"Clinico-pathological profile of endometrial carcinoma in young women (under 40 years of age)","volume":"10","author":"Colafranceschi","year":"1989","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/09513590400021201","article-title":"Polycystic ovary syndrome and gynecological cancers: is there a link?","volume":"20","author":"Gadducci","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib28","first-page":"417","article-title":"Adenocarcinoma of the endometrium in women 40 years of age or younger","volume":"64","author":"Gallup","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib29","first-page":"845","article-title":"Endometrial carcinoma in young women. A report of four cases","volume":"34","author":"Honore","year":"1989","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/gyno.1997.4656","article-title":"Increased expression of LH\/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women","volume":"65","author":"Konishi","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/humrep\/dei420","article-title":"The association between polycystic ovaries and endometrial cancer","volume":"21","author":"Pillay","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib32","first-page":"38","article-title":"A population-based case-control study of endometrial cancer in Shanghai","volume":"49","author":"Shu","year":"1991","journal-title":"China. Int J Cancer"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib33","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib34","first-page":"875","article-title":"Metabolic disorders and breast cancer risk (United States)","volume":"12","author":"Baron","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0015-0282(16)57408-1","article-title":"Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy","volume":"63","author":"Donesky","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib36","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/1097-0142(196902)23:2<352::AID-CNCR2820230212>3.0.CO;2-4","article-title":"Epidemiology of cancer of the ovary","volume":"23","author":"Wynder","year":"1969","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2009.10.012_bib38","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1677\/ERC-08-0075","article-title":"Epithelial ovarian cancer: testing the androgens hypothesis","volume":"15","author":"Olsen","year":"2008","journal-title":"Endocr Relat Cancer"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209038722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209038722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:44:45Z","timestamp":1758008685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028209038722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0015028209038722"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.10.012","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome)","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}